Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Nick West
Job title: Consultant Cardiologist
Dr West qualified from Trinity Hall, Cambridge and St Thomas’ Hospital Medical School, London. He subsequently trained in Cardiology at the John Radcliffe Hospital, Oxford and undertook research in the field of vascular biology and vein graft disease in the Department of Cardiovascular Medicine, University of Oxford and the Cardiovascular Division, Duke University, North Carolina. USA. Dr West… View more
Job title: Medical Director
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Paul Sorajja is an Interventional Cardiologist at the Banner Health in Phoenix, Arizona.Dr Sorajja's clinical practice specialises in interventional cardiology, with a focus on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the first transcatheter mitral valve replacement in the US for a patient with native mitral regurgitation in 2015,… View more
Michael D Shapiro
Job title: Director of the Center for Preventive Cardiology
Personal History Dr Shapiro lives in Winston-Salem with his wife and their two children. In his spare time, he enjoys travelling and hiking. Academic History Dr Shapiro completed medical school in 1998 at the UMDNJ School of Osteopathic Medicine. After completing a cardiology fellowship at the Beth Israel Medical Center, he spent two additional years in a clinical and research… View more
Cardiomyopathies: Management of Cardiomyopathies with Dr Michelle Kittleson
Author(s): Michelle Kittleson Added: 10 months ago
Learn about the management of HFrEF and HFpEF from Dr Michelle Kittleson (Cedars-Sinai Heart Institute, Los Angeles, US).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.In this lecture, Dr Kittleson provides an in-depth review of the management of HFrEF… View more

Heart Failure
Advancing Patient Care in Hypertrophic Cardiomyopathy: Key Insights from the HFA 2024
Author(s): Ahmad Masri , Added: 2 years ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive… View more

Guidelines & Statements

Heart Failure
Pitt Lim

Author

Job title: Cardiologist
Dr Lim completed his MBBS at the University of Newcastle-upon-Tyne Medical School in 1990. He then undertook higher specialist training cardiovascular medicine at Ninewell University Hospital and Medical School, Dundee from 1994 to 2000. During this period he completed his MD in hypertensive heart disease and contributed to the development of the “Dundee Step Test” and 20 peer reviewed… View more
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 1 year ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure
Brian Zenger
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

Imaging & Diagnostics
Personal History Brian Zenger is based in Salt Lake City, where he is currently an MD/PhD Student at the University of Utah. Academic History Brian Zenger is currently an MD/PhD Student at the University of Utah, Salt Lake City. His research interests include the electrical function of the heart, including cardiac electrophysiology. He is particularly interested in mathematical and… View more
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure